Selvita is a preclinical contract research organization. It operates in two segments: Drug Discovery and Drug Development. The Drug Discovery segment offers in vivo pharmacology and toxicology, bioinformatics, antigen design and validation, CMC analytical support, antibody engineering, and other solutions. The Drug Development segment specializes in biosimilarity assessment, preformulation studies, binding assays, identification and characterization of impurities, quality control, etc.